about
MR Elastography of Liver Disease: State of the Art.Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.Non-invasive markers for hepatic fibrosisDynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease.A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia.Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model.Liver fibrosis: an intravoxel incoherent motion (IVIM) study.Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.Hepatic venous pressure gradient: clinical use in chronic liver disease.Molecular serum markers of liver fibrosis.Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.Invasive and non-invasive assessment of portal hypertension.Normal values of liver elasticity measured by real-time tissue elastography (RTE) in healthy infants and children.Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C.Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver BiopsiesSerum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C.Measurement of liver T₁ and T₂ relaxation times in an experimental mouse model of liver fibrosis.Interobserver discrepancy in liver fibrosis using transient elastography.
P2860
Q30403258-D394A512-AEB4-4FD0-BB5E-1746F743EA9AQ30467234-0B903BF1-12DF-4C41-B574-C8A43C4E7718Q30474093-E491255C-C8E0-4B67-9600-4363B94BA554Q30474570-6D1C3DFC-4B0A-4756-A1AD-31F6D987F371Q33395398-85D36FFA-83F0-4AA3-8185-214F69978352Q33768700-6BF9A5D5-081D-4197-8E94-241CEC8822A1Q34159097-9E2022E2-902E-4F36-83CD-284DA78D6C6CQ36089694-E0F59BE5-76BC-4EEA-9BE0-57D95D102026Q37711328-C0CE8B9E-BA58-4CE6-A555-EAF693B59998Q38032835-9AAB71C8-857C-4857-B434-D83731CA7D7DQ38303313-26ED2D42-B42D-401D-9A36-046E6852FD69Q39210299-53E4D8E3-A4B0-45C3-AA41-07B65E46B729Q39699420-5C561B46-9C32-4EDD-BA90-2021E59908B3Q40428093-0234C28D-2CF9-4585-A9EE-8A34FAE12DA5Q41783506-E8FECF05-5A30-49AC-8760-0A0B8FA9C0ADQ51278552-2B477C52-5871-42B2-82EB-482BE4483D10Q51423153-A79DD9C4-F758-41C5-A256-53282033EA4DQ53105728-FB7BA3FE-35EA-4145-9F0A-F8BC3DE09453
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of fibrosis in chronic liver diseases.
@en
Assessment of fibrosis in chronic liver diseases.
@nl
type
label
Assessment of fibrosis in chronic liver diseases.
@en
Assessment of fibrosis in chronic liver diseases.
@nl
prefLabel
Assessment of fibrosis in chronic liver diseases.
@en
Assessment of fibrosis in chronic liver diseases.
@nl
P2860
P1476
Assessment of fibrosis in chronic liver diseases.
@en
P2093
P2860
P356
10.1111/J.1751-2980.2008.00356.X
P577
2009-02-01T00:00:00Z